Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Krishna Institute of Medical Sciences's Other Operating Expense for the
three
months ended in Jun. 2026 was ₹5,996 Mil.
Its Other Operating Expense for the trailing twelve months (TTM) ended in Jun. 2026 was ₹24,482 Mil.
Krishna Institute of Medical Sciences's quarterly Other Operating Expense
declined
from Dec. 2025 (₹6,806 Mil) to Mar. 2026 (₹5,404 Mil) but then
increased
from Mar. 2026 (₹5,404 Mil) to Jun. 2026 (₹5,996 Mil).
Krishna Institute of Medical Sciences's annual Other Operating Expense
increased
from Mar. 2024 (₹4,288 Mil) to Mar. 2025 (₹5,626 Mil) and
increased
from Mar. 2025 (₹5,626 Mil) to Mar. 2026 (₹7,971 Mil).
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Krishna Institute of Medical Sciences Other Operating Expense Chart
Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)
Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.
Other Operating Expense for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹24,482 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Other Operating Expense of ₹24,482 Mil mean?
Krishna Institute of Medical Sciences (NSE:KIMS) has a Other Operating Expense of ₹24,482 Mil as of Jun. 2026. Other operating expenses that a company records on its income statement. View historical data on Krishna Institute of Medical Sciences and its competitors.
Is Krishna Institute of Medical Sciences' Other Operating Expense too high?
Krishna Institute of Medical Sciences' current Other Operating Expense is ₹24,482 Mil. Overall, Krishna Institute of Medical Sciences has a GF Score™ of 87/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Krishna Institute of Medical Sciences' Other Operating Expense compare to HCA and THC?
Krishna Institute of Medical Sciences' Other Operating Expense of ₹24,482 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Operating Expense for a Healthcare Providers & Services company?
A good Other Operating Expense depends on the Healthcare Providers & Services industry context. However, Other Operating Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Operating Expense mean?
A high Other Operating Expense can signal that a stock is expensive relative to its fundamentals. Other operating expenses that a company records on its income statement. View historical data on Krishna Institute of Medical Sciences and its competitors. Krishna Institute of Medical Sciences's current Other Operating Expense is ₹24,482 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Krishna Institute of Medical Sciences stock overvalued right now?
Based on GuruFocus' analysis, Krishna Institute of Medical Sciences (NSE:KIMS) is currently considered Fairly Valued. The stock's GF Value™ is ₹857.66, compared to a current price of ₹809.10 — trading 5.7% below its estimated fair value. The current Other Operating Expense is ₹24,482 Mil. Krishna Institute of Medical Sciences' overall GF Score™ is 87/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Operating Expense calculated?
Other Operating Expense is calculated from a company's financial statements. For Krishna Institute of Medical Sciences (NSE:KIMS), the current Other Operating Expense is ₹24,482 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Krishna Institute of Medical Sciences (NSE:KIMS) Overvalued in 2026?
Based on GuruFocus' analysis, Krishna Institute of Medical Sciences stock appears to be undervalued.
The current stock price of ₹809.10 is trading 5.7% below its estimated GF Value™ of ₹857.66.
GuruFocus considers Krishna Institute of Medical Sciences to be Fairly Valued.
Key valuation signals for NSE:KIMS:
Other Operating Expense: ₹24,482 Mil
GF Value™: ₹857.66 vs. price of ₹809.10 (5.7% below fair value)
No single metric tells the full story. See the NSE:KIMS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Krishna Institute of Medical Sciences Ltd is a healthcare group in Secunderabad and Telangana. It offers a comprehensive range of healthcare services, including oncology, cardiac sciences, neurosciences, gastric sciences, orthopedics, renal sciences, organ transplantation, mother and child care, and many more. The firm generates key revenue from Hospital services and Pharmacy.
87GF Score
Get the complete analysis for NSE:KIMS
Other Operating Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:KIMS has been successfully added to your 
